Circadian clocks in mood-related behaviors

Annals of Medicine

Volumn 42, Issue 4, 2010, Pages 241-251

  Albrecht, Urs ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Depression; Dopamine; Light therapy; Lithium; SAD; Stress; Synchronization

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CRYPTOCHROME 1; CRYPTOCHROME 2; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; MELATONIN; NEUROLEPTIC AGENT; PER2 PROTEIN; PROTEIN BMAL1; RAB PROTEIN; TRANSCRIPTION FACTOR CLOCK;

BIPOLAR DISORDER; CIRCADIAN RHYTHM; DOPAMINE METABOLISM; GENE MUTATION; HUMAN; LIGHT DARK CYCLE; LIGHT EXPOSURE; MOOD DISORDER; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; SEASONAL AFFECTIVE DISORDER; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DEPRIVATION; SLEEP DISORDER; SOCIAL STRESS; SUPRACHIASMATIC NUCLEUS;

AFFECT; ANIMALS; BIOLOGICAL CLOCKS; CIRCADIAN RHYTHM; HUMANS; MENTAL DISORDERS; MOOD DISORDERS;

EID: 77952154756     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853891003677432     Document Type: Review

References (97)

1. Liu AC, Lewis WG, Kay SA. Mammalian circadian signaling networks and therapeutic targets. Nat Chem Biol. 2007; 3:630-639
2. Kalsbeek A, Palm IF, La Fleur SE, Scheer FA, Perreau-Lenz S, Ruiter M, et al. SCN outputs and the hypothalamic balance of life. J Biol Rhythms. 2006;21:458-469
3. Albrecht U, Sun ZS, Eichele G, Lee CC. A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell. 1997;91:1055-1064
4. Ya n L, Silver R. Differential induction and localization of mPer1 and mPer2 during advancing and delaying phase shifts. Eur J Neurosci. 2002;16:1531-1540
5. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet. 2008;9:764-775
6. Hampp G, Ripperger JA, Houben T, Schmutz I, Blex C, Perreau-Lenz S, et al. Regulation of monoamine oxidase A by circadian-clock components implies clock infl uence on mood. Curr Biol. 2008;18:678-683
7. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 2002;110:251-260 (Pubitemid 34876552) (Pubitemid 34876552)
8. Meng QJ, Logunova L, Maywood ES, Gallego M, Lebiecki J, Brown TM, et al. Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron. 2008;58:78-88.
9. Eide EJ, Woolf MF, Kang H, Woolf P, Hurst W, Camacho F, et al. Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. Mol Cell Biol. 2005;25:2795-2807
10. Shirogane T, Jin J, Ang XL, Harper JW. SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein. J Biol Chem. 2005;280:26863-26872
11. Reischl S, Vanselow K, Westermark PO, Thierfelder N, Maier B, Herzel H, et al. Beta-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics. J Biol Rhythms. 2007;22:375-386
12. Busino L, Bassermann F, Maiolica A, Lee C, Nolan PM, Godinho SI, et al. SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science. 2007;316:900-904
13. Siepka SM, Yoo SH, Park J, Song W, Kumar V, Hu Y, et al. Circadian mutant Overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell. 2007;129:1011-1023
14. Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J. Sirtuins: the 'magnifi cent seven', function, metabolism and longevity. Ann Med. 2007;39: 335-345
15. Asher G, Gatfi eld D, Stratmann M, Reinke H, Dibner C, Kreppel F, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell. 2008;134:317-328
16. Bunney WE, Bunney BG. Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology. 2000;22: 335-345
17. Fukuhara C, Dirden JC, Tosini G. Circadian expression of period 1, period 2, and arylalkylamine N-acetyltransferase mRNA in the rat pineal gland under different light conditions. Neurosci Lett. 2000;286:167-170
18. Ishida A, Mutoh T, Ueyama T, Bando H, Masubuchi S, Nakahara D, et al. Light activates the adrenal gland: timing of gene expression and glucocorticoid release. Cell Metab. 2005;2:297-307.
19. Oster H, Damerow S, Kiessling S, Jakubcakova V, Abraham D, Tian J, et al. The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab. 2006;4:163-173
20. Buijs RM, van Eden CG, Goncharuk VD, Kalsbeek A. The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J Endocrinol. 2003;177:17-26.
21. Stratmann M, Schibler U. Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J Biol Rhythms. 2006;21:494-506.
22. Scott AJ. Shift work and health. Prim Care. 2000;27:1057-1079
23. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. Seasonal affective disorder. A description of the syndrome and preliminary fi ndings with light therapy. Arch Gen Psychiatry. 1984;41:72-80.
24. Lewy AJ, Sack RL, Miller LS, Hoban TM. Antidepressant and circadian phase-shifting effects of light. Science. 1987; 235:352-354
25. Srinivasan V, Smits M, Spence W, Lowe AD, Kayumov L, Pandi-Perumal SR, et al. Melatonin in mood disorders. World J Biol Psychiatry. 2006;7:138-151
26. Kripke DF. Light treatment for nonseasonal depression: speed, effi cacy, and combined treatment. J Affect Disord. 1998;49:109-117
27. Terman M, Terman JS. Light therapy for seasonal and non-seasonal depression: effi cacy, protocol, safety, and side effects. CNS Spectr. 2005;10:647-63; quiz 72.
28. Wirz-Justice A, Benedetti F, Berger M, Lam RW, Martiny K, Terman M, et al. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med. 2005;35: 939-944
29. Gerbaldo H, Demisch L, Cardinali DP. Light exposure patterns in schizophrenia. Acta Psychiatr Scand. 1992;85: 94-95
30. Vigano D, Lissoni P, Rovelli F, Roselli MG, Malugani F, Gavazzeni C, et al. A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia. Neuro Endocrinol Lett. 2001;22:137-141
31. Young AH. Cortisol in mood disorders. Stress. 2004;7:205-208
32. Yelamanchili SV, Pendyala G, Brunk I, Darna M, Albrecht U, Ahnert-Hilger G. Differential sorting of the vesicular gluta-mate transporter 1 into a defi ned vesicular pool is regulated by light signaling involving the clock gene Period2. J Biol Chem. 2006;281:15671-15679
33. Darna M, Schmutz I, Richter K, Yelamanchili SV, Pendyala G, Holtje M, et al. Time of day-dependent sorting of the vesicular glutamate transporter to the plasma membrane. J Biol Chem. 2009;284:4300-4307
34. Abarca C, Albrecht U, Spanagel R. Cocaine sensitization and reward are under the infl uence of circadian genes and rhythm. Proc Natl Acad Sci USA. 2002;99:9026-9030
35. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, et al. The clock gene Per2 infl u-ences the glutamatergic system and modulates alcohol consumption. Nat Med. 2005;11:35-42.
36. Deery MJ, Maywood ES, Chesham JE, Sladek M, Karp NA, Green EW, et al. Proteomic analysis reveals the role of synaptic vesicle cycling in sustaining the suprachiasmatic circadian clock. Curr Biol. 2009;19:2031-2036
37. Kapfhamer D, Valladares O, Sun Y, Nolan PM, Rux JJ, Arnold SE, et al. Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse. Nat Genet. 2002;32:290-295
38. Reynolds CF 3rd, Kupfer DJ. Sleep research in affective illness: state of the art circa, 1987. Sleep. 1987; 10, 199-215.
39. Nakao M, Yano E. Reporting of somatic symptoms as a screening marker for detecting major depression in a population of Japanese white-collar workers. J Clin Epidemiol. 2003;56:1021-1026
40. Rocha FL, Hara C, Rodrigues CV, Costa MA, Castro e Costa E, Fuzikawa C, et al. Is insomnia a marker for psychiatric disorders in general hospitals? Sleep Med. 2005; 6:549-553
41. Armitage R. Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand Suppl. 2007:104-115 (Pubitemid 46114845) (Pubitemid 46114845)
42. Borbely AA. A two process model of sleep regulation. Hum Neurobiol. 1982;1:195-204.
43. Wirz-Justice A, Van den Hoofdakker RH. Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry. 1999;46:445-453
44. Balsalobre A, Damiola F, Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell. 1998;93:929-937
45. Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, et al. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science. 2000;289:2344-2347
46. Yamaguchi N, Maeda K, Kuromaru S. The effects of sleep deprivation on the circadian rhythm of plasma cortisol levels in depressive patients. Folia Psychiatr Neurol Jpn. 1978;32: 479-487
47. Moore-Ede MC. Physiology of the circadian timing system: predictive versus reactive homeostasis. Am J Physiol. 1986; 250:R737-52.
48. Meerlo P, Sgoifo A, Turek F W. The effects of social defeat and other stressors on the expression of circadian rhythms. Stress. 2002;5:15-22.
49. Horseman ND, Ehret CF. Glucocorticosteroid injection is a circadian zeitgeber in the laboratory rat. Am J Physiol. 1982; 243:R373-8.
50. Albers HE, Yogev L, Todd RB, Goldman BD. Adrenal cor-ticoids in hamsters: role in circadian timing. Am J Physiol. 1985;248:R434-8.
51. Hlastala SA, Frank E. Adapting interpersonal and social rhythm therapy to the developmental needs of adolescents with bipolar disorder. Dev Psychopathol. 2006;18:1267-1288
52. Roenneberg T, Wirz-Justice A, Merrow M. Life between clocks: daily temporal patterns of human chronotypes. J Biol Rhythms. 2003;18:80-90.
53. Walker E, Kestler L, Bollini A, Hochman KM. Schizophrenia: etiology and course. Annu Rev Psychol. 2004;55:401-430
54. Grandin LD, Alloy LB, Abramson LY. The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation. Clin Psychol Rev. 2006;26:679-694
55. Abe M, Herzog ED, Yamazaki S, Straume M, Tei H, Sakaki Y, et al. Circadian rhythms in isolated brain regions. J Neurosci. 2002;22:350-356
56. Laposky A, Easton A, Dugovic C, Walisser J, Bradfi eld C, Turek F. Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep. 2005;28:395-409.
57. Naylor E, Bergmann BM, Krauski K, Zee PC, Takahashi JS, Vitaterna MH, et al. The circadian clock mutation alters sleep homeostasis in the mouse. J Neurosci. 2000;20:8138-8143
58. Wisor JP, O'Hara BF, Terao A, Selby CP, Kilduff TS, Sancar A, et al. A role for cryptochromes in sleep regulation. BMC Neurosci. 2002;3:20.
59. Dudley CA, Erbel-Sieler C, Estill SJ, Reick M, Franken P, Pitts S, et al. Altered patterns of sleep and behavioral adaptability in NPAS2-defi cient mice. Science. 2003;301:379-383
60. He Y, Jones CR, Fujiki N, Xu Y, Guo B, Holder JL Jr, et al. The transcriptional repressor DEC2 regulates sleep length in mammals. Science. 2009;325:866-870
61. Franken P, Lopez-Molina L, Marcacci L, Schibler U, Tafti M. The transcription factor DBP affects circadian sleep consolidation and rhythmic EEG activity. J Neurosci. 2000; 20:617-625
62. Hu WP, Li JD, Zhang C, Boehmer L, Siegel JM, Zhou QY. Altered circadian and homeostatic sleep regulation in prok-ineticin 2-defi cient mice. Sleep. 2007;30:247-256
63. Kopp C, Albrecht U, Zheng B, Tobler I. Homeostatic sleep regulation is preserved in mPer1 and mPer2 mutant mice. Eur J Neurosci. 2002;16:1099-1106
64. Shiromani PJ, Xu M, Winston EM, Shiromani SN, Gerashchenko D, Weaver DR. Sleep rhythmicity and home-ostasis in mice with targeted disruption of mPeriod genes. Am J Physiol Regul Integr Comp Physiol. 2004;287:R47-57.
65. Easton A, Arbuzova J, Turek FW. The circadian Clock mutation increases exploratory activity and escape-seeking behavior. Genes Brain Behav. 2003;2:11-19.
66. Roybal K, Theobold D, Graham A, Dinieri JA, Russo SJ, Krishnan V, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA. 2007;104:6406-6411
67. Karl T, Burne TH, Herzog H. Effect of Y1 receptor defi-ciency on motor activity, exploration, and anxiety. Behav Brain Res. 2006;167:87-93.
68. Karl T, Duffy L, Herzog H. Behavioural profi le of a new mouse model for NPY defi ciency. Eur J Neurosci. 2008; 28:173-180
69. Wersinger SR, Caldwell HK, Christiansen M, Young WS 3rd. Disruption of the vasopressin 1b receptor gene impairs the attack component of aggressive behavior in mice. Genes Brain Behav. 2007;6:653-660
70. Iitaka C, Miyazaki K, Akaike T, Ishida N. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem. 2005;280:29397-29402
71. Kaladchibachi SA, Doble B, Anthopoulos N, Woodgett JR, Manoukian AS. Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. J Circadian Rhythms. 2007;5:3.
72. Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science. 2006;311:1002-1005
73. Partonen T, Treutlein J, Alpman A, Frank J, Johansson C, Depner M, et al. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med. 2007; 39:229-238
74. Hampp G, Albrecht U. The circadian clock and mood-related behavior. Comm Int Biol. 2008;1:1-3.
75. Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7: 137-151
76. Randrup A, Braestrup C. Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology (Berl). 1977;53:309-314
77. McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC, et al. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci USA. 2005;102:9377-9381
78. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell. 2007;131:391-404.
79. Qu T, Dong K, Sugioka K, Yamadori T. Demonstration of direct input from the retina to the lateral habenular nucleus in the albino rat. Brain Res. 1996;709:251-258
80. Matsumoto M, Hikosaka O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature. 2007; 447:1111-1115
81. Hirsh J, Riemensperger T, Coulom H, Iche M, Coupar J, Birman S. Roles of dopamine in circadian rhythmicity and extreme light sensitivity of circadian entrainment. Curr Biol. 2010;20:209-214
82. Jones CR, Campbell SS, Zone SE, Cooper F, DeSano A, Murphy PJ, et al. Familial advanced sleep-phase syndrome: A short-period circadian rhythm variant in humans. Nat Med. 1999;5:1062-1065
83. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 2001;291:1040-1043
84. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature. 2005;434:640-644
85. Pedrazzoli M, Louzada FM, Pereira DS, Benedito-Silva AA, Lopez AR, Martynhak BJ, et al. Clock polymorphisms and circadian rhythms phenotypes in a sample of the Brazilian population. Chronobiol Int. 2007;24:1-8.
86. Carpen JD, von Schantz M, Smits M, Skene DJ, Archer SN. A silent polymorphism in the PER1 gene associates with extreme diurnal preference in humans. J Hum Genet. 2006;51:1122-1125
87. Ebisawa T, Uchiyama M, Kajimura N, Mishima K, Kamei Y, Katoh M, et al. Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep. 2001;2:342-346
88. Archer SN, Robilliard DL, Skene DJ, Smits M, Williams A, Arendt J, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep. 2003; 26:413-415
89. Viola AU, Archer SN, James LM, Groeger JA, Lo JC, Skene DJ, et al. PER3 polymorphism predicts sleep structure and waking performance. Curr Biol. 2007;17:613-618
90. Benedetti F, Radaelli D, Bernasconi A, Dallaspezia S, Falini A, Scotti G, et al. Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients. Genes Brain Behav. 2008; 7:20-25
91. Sookoian S, Gemma C, Gianotti TF, Burgueno A, Castano G, Pirola CJ. Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr. 2008;87:1606-1615
92. Johansson C, Willeit M, Smedh C, Ekholm J, Paunio T, Kieseppa T, et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology. 2003;28:734-739
93. Woon PY, Kaisaki PJ, Braganca J, Bihoreau MT, Levy JC, Farrall M, et al. Aryl hydrocarbon receptor nuclear translo-cator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci USA. 2007;104:14412-14417
94. Lavebratt C, Sjoholm LK, Partonen T, Schalling M, Forsell Y. PER2 variation is associated with depression vulnerability. Am J Med Genet B Neuropsychiatr Genet. 2010;153B: 570-581
95. McGrath CL, Glatt SJ, Sklar P, Le-Niculescu H, Kuczenski R, Doyle AE, et al. Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry. 2009;9:70.
96. Peng ZW, Chen XG, Wei Z. Cryptochrome1 maybe a candidate gene of schizophrenia. Med Hypotheses. 2007;69: 849-851
97. Nievergelt CM, Kripke DF, Remick RA, Sadovnick AD, McElroy SL, Keck PE Jr, et al. Examination of the clock gene Cryptochrome 1 in bipolar disorder: mutational analysis and absence of evidence for linkage or association. Psychiatr Genet. 2005;15:45-52.